BUCKINGHAM STRATEGIC WEALTH, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 81 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
BUCKINGHAM STRATEGIC WEALTH, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,000
-50.0%
10,0000.0%0.00%
Q2 2022$2,000
-60.0%
10,0000.0%0.00%
Q1 2022$5,000
-16.7%
10,0000.0%0.00%
Q4 2021$6,000
-80.0%
10,000
-44.4%
0.00%
-100.0%
Q3 2021$30,0000.0%18,0000.0%0.00%0.0%
Q2 2021$30,0000.0%18,0000.0%0.00%0.0%
Q1 2021$30,000
+25.0%
18,000
+21.5%
0.00%0.0%
Q4 2020$24,000
+71.4%
14,8190.0%0.00%0.0%
Q3 2020$14,000
+40.0%
14,819
-7.8%
0.00%0.0%
Q2 2020$10,00016,0800.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders